• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的肠道微生物群

The intestinal microbiota in inflammatory bowel diseases.

作者信息

Sartor R Balfour

机构信息

Division of Gastroenterology and Hepatology, Center for Gastrointestinal Biology and Disease, Department of Medicine, Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.

出版信息

Nestle Nutr Inst Workshop Ser. 2014;79:29-39. doi: 10.1159/000360674. Epub 2014 Sep 5.

DOI:10.1159/000360674
PMID:25227293
Abstract

Abundant clinical and experimental evidence supports a role for resident microbiota in Crohn's disease and pouchitis, and probably in ulcerative colitis (UC). These disorders occur in areas of highest bacterial concentrations. Pouchitis and Crohn's colitis respond to antibiotics, while pouchitis and UC can be treated with probiotics. Serologic markers recognizing intestinal bacteria and yeast are present in the majority of Crohn's disease patients and may predict disease aggressiveness. Abnormal profiles of fecal and mucosally associated enteric bacteria (dysbiosis) occur in Crohn's disease, UC, pouchitis and experimental enterocolitis, with a proliferation of aggressive species that promote experimental colitis and a corresponding decrease in protective bacterial subsets. Many of these protective bacteria produce short-chain fatty acids, including butyrate, that promote epithelial barrier function, inhibit effector immune responses and induce regulatory T cell subsets. Furthermore, certain Clostridia species stimulate regulatory T cells that can inhibit intestinal inflammation. Animal models of chronic, immune-mediated enterocolitis convincingly demonstrate that enteric resident bacteria stimulate effector immune cells in susceptible hosts and that a subset of enteric bacteria has particularly aggressive activities, with host and bacterial specificity. Recent studies suggest parallel and perhaps complementary roles for enteric viruses, which have only very recently been identified.

摘要

大量临床和实验证据支持常驻微生物群在克罗恩病和袋炎中起作用,可能在溃疡性结肠炎(UC)中也起作用。这些疾病发生在细菌浓度最高的区域。袋炎和克罗恩结肠炎对抗生素有反应,而袋炎和UC可用益生菌治疗。大多数克罗恩病患者存在识别肠道细菌和酵母的血清学标志物,这些标志物可能预测疾病的侵袭性。在克罗恩病、UC、袋炎和实验性小肠结肠炎中出现粪便和黏膜相关肠道细菌的异常谱(生态失调),具有促进实验性结肠炎的侵袭性菌种增殖以及相应的保护性细菌亚群减少。许多这些保护性细菌产生短链脂肪酸,包括丁酸,其可促进上皮屏障功能、抑制效应免疫反应并诱导调节性T细胞亚群。此外,某些梭菌属菌种刺激可抑制肠道炎症的调节性T细胞。慢性免疫介导性小肠结肠炎的动物模型令人信服地证明,肠道常驻细菌在易感宿主中刺激效应免疫细胞,并且一部分肠道细菌具有特别强的侵袭性活动,具有宿主和细菌特异性。最近的研究表明肠道病毒具有平行且可能互补的作用,而肠道病毒直到最近才被发现。

相似文献

1
The intestinal microbiota in inflammatory bowel diseases.炎症性肠病中的肠道微生物群
Nestle Nutr Inst Workshop Ser. 2014;79:29-39. doi: 10.1159/000360674. Epub 2014 Sep 5.
2
Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?调节炎症性肠病中的微生物群:益生元、益生菌还是粪便移植?
Proc Nutr Soc. 2014 Nov;73(4):490-7. doi: 10.1017/S0029665114000639. Epub 2014 Jun 27.
3
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.肠道微生物群为溃疡性结肠炎带来了新的治疗策略。
World J Gastroenterol. 2014 Nov 14;20(42):15657-63. doi: 10.3748/wjg.v20.i42.15657.
4
[Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].[肠道菌群在炎症性肠病中的作用及益生菌在其治疗中的地位]
Tunis Med. 2005 Mar;83(3):132-6.
5
Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.肠道微生物群与炎症性肠病:抗生素在疾病管理中的作用。
Postgrad Med. 2014 Jul;126(4):7-19. doi: 10.3810/pgm.2014.07.2779.
6
Microbial-host interactions in inflammatory bowel diseases and experimental colitis.炎症性肠病和实验性结肠炎中的微生物-宿主相互作用。
Nestle Nutr Workshop Ser Pediatr Program. 2009;64:121-32; discussion 132-7, 251-7. doi: 10.1159/000235787. Epub 2009 Aug 19.
7
Bacteria in the pathogenesis of inflammatory bowel disease.细菌在炎症性肠病发病机制中的作用
Curr Opin Infect Dis. 2006 Oct;19(5):475-84. doi: 10.1097/01.qco.0000244054.69253.f3.
8
Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases.肠道微生物群和粪便移植在炎症性肠病中的作用。
J Dig Dis. 2014 Dec;15(12):641-6. doi: 10.1111/1751-2980.12211.
9
Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.袋状结构炎症与特定细菌分类群丰度的降低有关。
Gastroenterology. 2015 Sep;149(3):718-27. doi: 10.1053/j.gastro.2015.05.041. Epub 2015 May 27.
10
Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病的病因及发病机制的当前概念
Gastroenterol Clin North Am. 1995 Sep;24(3):475-507.

引用本文的文献

1
The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer's disease.益生菌、益生元及后生元的作用:阿尔茨海默病中胶质细胞激活的细胞及分子途径
Front Neurosci. 2025 Jun 25;19:1598011. doi: 10.3389/fnins.2025.1598011. eCollection 2025.
2
Exploring Gut Microbiota in Systemic Lupus Erythematosus: Insights and Biomarker Discovery Potential.探索系统性红斑狼疮中的肠道微生物群:见解与生物标志物发现潜力
Clin Rev Allergy Immunol. 2025 Apr 11;68(1):42. doi: 10.1007/s12016-025-09051-4.
3
The Gut-Brain Axis in Opioid Use Disorder: Exploring the Bidirectional Influence of Opioids and the Gut Microbiome-A Comprehensive Review.
阿片类物质使用障碍中的肠-脑轴:探索阿片类物质与肠道微生物群的双向影响——综述
Life (Basel). 2024 Sep 25;14(10):1227. doi: 10.3390/life14101227.
4
The Gut-Brain Axis in Autoimmune Diseases: Emerging Insights and Therapeutic Implications.自身免疫性疾病中的肠-脑轴:新见解与治疗意义
Cureus. 2023 Nov 11;15(11):e48655. doi: 10.7759/cureus.48655. eCollection 2023 Nov.
5
Modeling microbiota-associated human diseases: from minimal models to complex systems.模拟微生物群相关的人类疾病:从极简模型到复杂系统。
Microbiome Res Rep. 2022 May 13;1(3):17. doi: 10.20517/mrr.2022.01. eCollection 2022.
6
Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn's Disease Patients.克罗恩病患者粪便来源细菌膜泡的宏基因组分析。
Cells. 2021 Oct 19;10(10):2795. doi: 10.3390/cells10102795.
7
Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.细菌代谢产物对肠道屏障功能和宿主免疫的影响:关注细菌代谢及其与肠道炎症的相关性。
Front Immunol. 2021 May 26;12:658354. doi: 10.3389/fimmu.2021.658354. eCollection 2021.
8
Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases.丁酸盐与结肠稳态的精细调节:对炎症性肠病的影响。
Int J Mol Sci. 2021 Mar 17;22(6):3061. doi: 10.3390/ijms22063061.
9
The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases.黏膜微生物群组成与宿主基因表达之间的相互作用与炎症性肠病中英夫利昔单抗的反应相关。
Microorganisms. 2020 Mar 20;8(3):438. doi: 10.3390/microorganisms8030438.
10
The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance.疼痛控制的“文化”:阿片类药物诱导的肠道菌群失调(OID)在抗伤害性耐受中的综述。
J Pain. 2020 Jul-Aug;21(7-8):751-762. doi: 10.1016/j.jpain.2019.11.015. Epub 2019 Dec 11.